Companies

Abilita Bio’s mission is to discover and develop transformative therapeutics by enabling
Biosortia Pharmaceuticals is a biopharmaceutical company focused on the development of
Digital Proteomics is developing a platform for rapid discovery of antibodies directly
DTx Pharma is developing a technology that enables delivery of double-stranded
Alumni
Discovery tumor-specific molecules for a new generation of cancer therapeutics.
Alumni
Lectenz Bio (fka Glycosensors & Diagnostics) is commercializing enabling technologies for
Alumni
The Molecular Assemblies story began more than 30 years ago as co- founders, Dr. Bill
Peresephone is a business taking a unique approach to gut microbiome health, understanding
Alumni
Primordial Genetics Inc. is developing Function Generator™, a novel combinatorial gain-of
Alumni
Proprietary lab-on-a-chip technology platform designed to individually identify,
High-throughput method of development and differentiation of stem cells to enable human
Sunomix Therapeutics is a biopharmaceutical company focusing on the development of cutting